Search clinical trials for: Postmenopausal Osteoporosis, Denosumab, Alvotech

Total 1633 results

Turku University Hospital

Completed

Sleep-disordered Breathing in Postmenopausal Women

Sleep Apnea
Hospital Regional 1o de Octubre
Universidad Nacional Autonoma de Mexico; National Polytechnic Institute, Mexico

Completed

Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment

Hyperparathyroidism, Primary | Hyperparathyroidism, Secondary | Hypovitaminosis D | Postmenopause | Postmenopausal Osteoporosis

Mexico
Alvotech Swiss AG

Completed

Auto-injector Real Life Handling in Patients

RA

Georgia, Ukraine
Alvotech Swiss AG

Completed

PK, Safety and Tolerability Study of AVT02 (Adalimumab) Pre-filled Syringe (PFS) vs, AVT02 Autoinjector (AI)

Phase 1

New Zealand
Alvotech Swiss AG

Completed

Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque Psoriasis

Plaque Psoriasis

Poland, Georgia, Iceland, Russian Federation, Ukraine
Alvotech Swiss AG

Completed

Pharmacokinetics, Safety and Tolerability Study of AVT02 to EU-approved and US-licensed Humira (Adalimumab)

Healthy Volunteers

New Zealand, Australia
University of Maryland, Baltimore
Syndax Pharmaceuticals

Terminated

Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery (0927GCC)

Stage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Triple-negative Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast Cancer

United States
Postgraduate Institute of Dental Sciences Rohtak

Completed

Impact of SRP on Bone Resorption and Systemic Inflammatory Markers in Postmenopausal Women With Periodontitis

Periodontitis

India
AMAG Pharmaceuticals, Inc.

Completed

Comparing Bioavailability When Preservative-free Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) is Administered as an Intramuscular Manual Injection or as a Subcutaneous Injection Using an Auto-injector in Healthy Post-menopausal Women

Comparing Bioavailability When Makena® is Administered in Healthy Post-menopausal Women

United States
University Hospital Inselspital, Berne
Medinova AG

Completed

Sustainability of Vaginal Estrogen Therapy in Postmenopausal Women

Postmenopause | Atrophy of Vagina

Switzerland
Dr. August Wolff GmbH & Co. KG Arzneimittel
proDERM GmbH

Completed

Investigation of Efficacy and Tolerability of WO 2707, a MoistCream Cremolum, in Postmenopausal Women Suffering From Symptoms of Vaginal Dryness

Vaginal Atrophy

Germany
Hospital Regional 1o de Octubre
Universidad Nacional Autonoma de Mexico; National Polytechnic Institute, Mexico

Completed

Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients

Hyperparathyroidism | Hypovitaminosis D | Postmenopausal Osteoporosis

Mexico
Sanofi

Completed

Study of Excretion Balance and Pharmacokinetics of [14C]-Sodium Valproate (3.7 MBq) in Healthy Postmenopausal or Permanently Sterile Female Subjects

Epilepsy

United Kingdom
AMAG Pharmaceuticals, Inc.

Terminated

Study Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) When Administered Via Subcutaneous Auto-injector vs Intramuscular Injection Via Needle and Syringe in Healthy Post-menopausal Women

Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) in Healthy Post-menopausal Women

United States
Pfizer

Completed

RW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S.

Breast Cancer

United States
University Institute of Maia
University of Southern Denmark; Universidade do Porto; Research Centre in Physical... and other collaborators

Completed

Effects of a Recreational Team Handball-based Programme on Health and Physical Fitness of Postmenopausal Women (H4HW)

Menopause

Portugal
SOLTI Breast Cancer Research Group

Completed

Onapristone as Preoperative Treatment for Postmenopausal Women With Hormone Receptor + and HER2- Breast Cancer (ONAWA)

Breast Cancer

Spain
Laboratoire des Adaptations Métaboliques à l'Exercice...
CREPS Auvergne Rhône-Alpes (AURA)

Completed

HIIT + RT on Body Composition and Gut Microbiota in Postmenopausal Women (PACWOMan) (PACWOMan)

Overweight | Postmenopausal Women

France
Federal University of Uberlandia

Completed

Effect of Mat Pilates Training on Women After Menopause

Physical Activity | Blood Pressure

Brazil
UNICANCER
Pfizer; NanoString Technologies, Inc.

Completed

Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women (NeoPAL)

Neoadjuvant Operable Breast Cancer

France
University of Alabama, Tuscaloosa

Completed

Acute Effects of Watermelon on Vascular Function and Serum Lycopene

Vascular Health of Postmenopausal Women

United States
Mylan Pharmaceuticals Inc

Completed

A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis

Atrophic Vaginitis

United States
NRG Oncology
National Cancer Institute (NCI)

Completed

Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

Breast Carcinoma | Cervical Carcinoma | Vaginal Carcinoma | Ovarian Carcinoma | Uterine Corpus Cancer | Vulvar Carcinoma | Postmenopausal

United States
Yeouido St. Mary's Hospital
Samsung Medical Center; Seoul National University Bundang Hospital

Completed

Use of Ibandronate in Diabetic Patients

Type 2 Diabetes | Osteoporosis, Postmenopausal

Korea, Republic of
University of Colorado, Denver

Completed

Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors

Breast Cancer | Stage II Breast Cancer | Stage III Breast Cancer

United States
Texas Tech University Health Sciences Center

Withdrawn

Tocotrienols for Skeletal Muscle Health (VitE-muscle)

Postmenopausal Women | Dynapenia

United States
Organon and Co

Completed

Bioequivalence of Nomegestrol Acetate (NOMAC) and Estradiol (E2) in Commercial Versus Phase 3 Pivotal Clinical Batches of NOMAC-E2 Tablets (P06328)

Healthy Postmenopausal Females
Ajman University

Completed

Salivary Calcium in Post-menopausal Women and Prevalence of Dental Caries

Salivary Calcium

India
Texas Tech University

Completed

8 Weeks of L-CIT Supplementation and LIRET on Vascular Function in Hypertensive Postmenopausal Women

Hypertension | Menopause

United States
Organon and Co

Completed

Efficacy of Tibolone Versus Transdermal E2/NETA on Sexual Function in Naturally Postmenopausal Women (P06089)

Sexual Dysfunction
Organon and Co

Completed

Comparison of Tibolone and Raloxifene on Bone Mineral Density in Osteopenic Postmenopausal Women (P06090) (STEP)

Osteopenia
Organon and Co

Completed

A Study to Investigate the Effects of Tibolone (Livial®) on Breast Tissue in Postmenopausal Women With Breast Cancer (Study 32971)(P06469) (STEM)

Breast Cancer
Organon and Co

Completed

A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219)

Postmenopausal Osteoporosis
Organon and Co

Completed

A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907)

Osteoporosis, Postmenopausal
Organon and Co

Completed

A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED)

Osteoporosis, Postmenopausal
Organon and Co

Completed

Tibolone Endometrium Study (Study 32972)(P06470) (THEBES)

Postmenopausal Women
Organon and Co

Completed

FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051)

Osteoporosis, Postmenopausal
Organon and Co

Completed

A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189)

Osteoporosis, Postmenopausal
Organon and Co

Completed

4-Week Study to Assess the Effect of Alendronate and Vitamin D3 Once Weekly on Fractional Calcium Absorption in Postmenopausal Osteoporotic Women (0217A-230)

Osteoporosis
Organon and Co

Completed

A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)

Vitamin D Deficiency | Osteoporosis
Organon and Co

Completed

Study of Investigational Drug in Osteoporosis (MK-0217-908)

Postmenopausal Osteoporosis
Riphah International University

Completed

High Intensity Resistance Training In Postmenopausal Women (HIRT) (HIRT)

Post Menopause

Pakistan
Yale University
Novartis Pharmaceuticals

Terminated

Neoadj ph 2 AI Plus Everolimus in Postmenopausal Women w/ ER Pos/HER2 Neg, Low Risk Score

Breast Cancer

United States
Pfizer

Completed

Palbociclib Plus Letrozole For Postmenopausal Women With HR(+) HER2(-) Advanced Breast Cancer For Whom Letrozole Is Deemed Appropriate

Advanced Breast Cancer Female

Mexico, Argentina, Brazil, Colombia
University of Delaware
National Institutes of Health (NIH)

Terminated

Vascular Dysfunction in Hypertensive Postmenopausal Women

Cardiovascular Diseases | Hypertension

United States
Sojournix, Inc.

Terminated

Phase 2 Study of SJX-653 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms

Hot Flashes

Belgium, Germany, Poland, United Kingdom
Instituto Nacional de Perinatologia Isidro Espinosa...

Active, not recruiting

Effect of Resveratrol and Vitamin C on Insulin Resistance Among Postmenopausal Women

Insulin Resistance | Postmenopausal

Mexico
University of Copenhagen

Completed

Training in a Local Community Aimed Upon Musculoskeletal Health Promotion for Postmenopausal Women

Age-Related Osteoporosis

Denmark
Syndax Pharmaceuticals

Completed

Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer

Breast Cancer | Estrogen Receptor Positive Breast Cancer

United States
Novartis Pharmaceuticals

No longer available

MAP Treatment Plan With Afinitor for Postmenopausal Women With Advanced HR+ Breast Cancer

Advanced Hormone Receptor Positive (HR+) Breast Cancer

3

Subscribe